Cargando…
Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma
BACKGROUND: Hypoalbuminemia adversely affects the clinical outcomes of various cancers. The purpose of this study was to estimate the prognostic value of hypoalbuminemia 3–5 weeks after treatment in patients with metastatic renal cell carcinoma (mRCC) who received sorafenib or sunitinib as first-lin...
Autores principales: | Cai, Wen, Zhang, Jin, Chen, Yonghui, Kong, Wen, Huang, Yiran, Huang, Jiwei, Zhou, Lixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436428/ https://www.ncbi.nlm.nih.gov/pubmed/28521783 http://dx.doi.org/10.1186/s40880-017-0214-7 |
Ejemplares similares
-
Comparison of efficacy, safety, and quality of life between sorafenib and sunitinib as first-line therapy for Chinese patients with metastatic renal cell carcinoma
por: Cai, Wen, et al.
Publicado: (2017) -
Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients
por: Huang, Jiwei, et al.
Publicado: (2021) -
Transitional cell carcinoma with extension of the renal vein and IVC tumor thrombus: report of three cases and literature review
por: Li, Mingyang, et al.
Publicado: (2016) -
Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens
por: Wang, Xun, et al.
Publicado: (2017) -
Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study
por: Cai, Wen, et al.
Publicado: (2019)